Staff

محمد محمود محمد أحمد البحيرى

محمد محمود محمد أحمد البحيرى

محمد محمود محمد أحمد البحيرى

drbahary@sci.psu.edu.eg

كلية العلوم بورسعيد

الكيمياء

مدرس مساعد

Awlilah, Mit ghamr, Dakahlyia, 35615, Egypt.

Biography

Short Biography

2020/3/25 Doctoral degree in Biochemistry Chemistry, Graduate school of Science, Kobe University, Kobe, hyogo, Japan, Mohammed El Behery: Studies on molecular functions of the human tumor suppressor protein 101F6 (ヒト癌抑制タンパク質101F6の分子機能に関する研究). Doctoral dissertation, Chemistry, Graduate school of Science, Kobe University, Kobe, hyogo, Japan, 2020. 2011–2013 Master’s degree in Biochemistry Faculty of Science, Port-Said University, Port-Said (Egypt), Mohammed El Behery: Antitumor and Antioxidant Activities of Some Nitrogen Heterocyclic Compounds. Master Thesis, Biochemistry Division, Chemistry Department, Faculty of Science, Port-Said University, Port-Said, Egypt, 2013. 2005–2009 BSc. In science, Chemistry Department Faculty of Science, Port-Said University, Port-Said (Egypt) The degree was: Very Good with Honors (81.3 %)

Educational Qualification

25/3/2020 Kobe University, Graduate School of Science, Chemistry Department, Kobe, Hyogo, Japan. Doctoral degree in Biochemistry, Doctor of Science, D.Sc. Thesis title: Studies on molecular functions of the human tumor suppressor protein 101F6 7/2013 6/2009 Port Said University, Faculty of Science, Chemistry Department, Port Said, Egypt. Master’s degree in Biochemistry, M.Sc. Thesis title: Antitumor and Antioxidant Activities of Some Nitrogen Heterocyclic Compounds Suez Canal University, Faculty of Science, Chemistry Department, Ismailia, Egypt. BSc. in Science, Chemistry

 

30/11/2020 Lecturer of Biochemistry: Port Said University, Faculty of Science, Chemistry Department, Port Said, Egypt. 4/2017- 3/2020 Research Assistant (RA): Kobe University, Graduate School of Science, Chemistry Department, Kobe, Hyogo, Japan. 9/2013-11/2020 Assistant Lecturer: Port Said University, Faculty of Science, Chemistry Department, Port Said, Egypt. 2/2010–7/2013 Demonstrator: Port Said University, Faculty of Science, Chemistry Department, Port Said, Egypt.

Academic And Professional Experience

Teaching and Work experience ➢ Biochemistry, Molecular biology, and Cancer Biology ➢ Vitamins, Lipid Metabolism, Protein Metabolism and Carbohydrate Metabolism, ➢ Immunology, Enzymology, Hormones, and Chromatographic techniques ➢ In vitro, in vivo anticancer therapies, Antioxidant measurements and Instrumental Analyses Research Interests ➢ Study the expression, purification, characterization, and functions of membrane proteins and other soluble proteins to understand biologically important processes at physiological and molecular level ➢ Study of amyloid fibrils mechanism and neurodegenerative diseases ➢ In vitro, in vivo anticancer therapies, cell cycle analyses, apoptosis, and Antioxidant measurements to design a safe and effective cancer treatment ➢ In silico molecular docking studies ➢ Nanodisc technology by reconstitution of a membrane protein into phospholipid bilayer nanodiscs to provide and mimic a membrane bound protein structure ➢ Gene therapy, Gene transfection, Molecular cloning, Western blotting technique ➢ Cell Culture (Yeast, Bacterial and Cancer cells)

Publications

Publications: 

2025 

  1. Alfaifi, M.Y., Abosakr, N.E.M., El Behery, M. et al. Synergistic Effects of Chitosan Nanocapsules with Tea Tree Oil, ZnO, and Vitamin C: Targeting Kidney Carcinoma through Multi-Pathway Proliferation Factors Inhibition and pro-Apoptotic Effects. J Clust Sci 36, 226 (2025). https://doi.org/10.1007/s10876-025-02925-9, Q1 WOS 

  1. Behery ME, Allam EI, Hassan N, Youghly NA. Bio-elimination of Chromium Using Bacillus Cereus Strains Isolated from Activated Sludge. Curr Microbiol. 2025 Dec 1;83(1):46. doi: 10.1007/s00284-025-04620-4. PMID: 41320704. Q3 WOS Q2 Scopus 

  1. Abdelrazek MA, Elghwab AI, Tabll AA, Elsayed EH, El Behery M. Evaluation of hyaluronic acid and type III procollagen peptide as predictors for treatment response to direct-acting antivirals. World J Virol. 2025 Jun 25;14(2):106479. doi: 10.5501/wjv.v14.i2.106479. PMID: 40575636; PMCID: PMC12188855. Q4 Scopus 

  1. Mohammed El Behery, Ruwaida I. El-Namaky, Ali H. Abu Almaaty, Ibrahim M. El-Deen. Biological and In Silico Studies of a Novel Pyrazolo[3,4-d]Thiazole Derivatives: Anticancer, Anti- Inflammatory, Molecular Docking, and SAR. Chemistry and biodiversity. 2025. Q3 WOS Q2 Scopus. 

 

2024 

  1. Mohammed El Behery, Dina M. Abo-Elmatty, Maha Alsunbul, Yassmina I. Mohey ElDeen, Doaa I. Mohamed, Emad Rashad Sindi, Maha H. Hashem, Ebtesam AlOlayan, Ibrahim Abdel Aziz Ibrahim, Ghazi A. Bamagous, Suraj Malii and Essa M. Saied. Exploration of the anticancer efficacy of a novel 1,3-thiazole analog in an ehrlich ascites carcinoma model: in vivo and in silico insights into hepatorenal protective potentials via the modulation of apoptosis, oxidative stress and inflammation. RSC Adv., 2025, 15, 20143. Q2 WOS 

  1. Rizzk, YW., El-Deen, I. M., Behery, M. E., Mourad, A. A. E., & Mohammed, F. Z. In vivo anticancer study of sodium 2-[(4-oxidobenzylidene)amino]-6H-1,3,4-thiadiazine-5-olate against Ehrlich ascites carcinoma via targeting PI3K/mTOR pathway. Chemical Biology & Drug Design,2024. 103, e14452. https://doi.org/10.1111/cbdd.14452. Q2 WOS 

  1. Kodous MA, Tabll AA, Elsayed EH, Behery ME, Abdelrazek MA. Predictive Value of Interleukin 6 and Interleukin 8 in Response to Treatment of Hepatitis C Virus. Clin Lab. 2024 Aug 1;70(8). doi: 10.7754/Clin.Lab.2024.240119. PMID: 39193955. Q4 Scopus 

  1. Mohammed El Behery, AhmedI. Elghwab, Ashraf A. Tabll, Elsherbiny H. Elsayed & Mohamed A. Abdelrazek (2024) Serum collagen IV as a predictor for response to direct-acting antivirals hepatitis C therapy, Journal of Immunoassay and Immunochemistry, 45:6, 539-548, DOI: 10.1080/15321819.2024.2415882. 

  1. Mohamed A. Abdelrazek , Hossam T. ElAgamy, Essam Attiad, Lamiaa A. Barakat, Mohammed El Behery. Reduced Serum Total Testosterone may Influence Male Colorectal Cancer Development and Severity. African journal of Biological Science (Q4). 2024.6.1109-1117. 

  1. Mohamed A. Abdelrazek , Hossam T. ElAgamy, Essam Attiad, Lamiaa A. Barakat, Mohammed El Behery. Increased Serum Calprotectin is Associated with Colorectal Carcinoma Development and Severity. African journal of Biological Science(Q4). 2024.6.1109-1117. 

  1. Behery, M.E., Abdel-Aziz, A.F., Elsayed, E.H., El-Diasty, D.M., Taha, S.I. (2024). Neutrophil/Lymphocyte and Lactate Dehydrogenase/Lymphocyte Ratios as Predictors of COVID- 19 Severity. In: El-Dossoki, F., Hassan, M., Shehata, A. (eds) Proceedings of The First International Conference on Green Sciences. ICGS 2023. Earth and Environmental Sciences Library. Springer, Cham. https://doi.org/10.1007/978-3-031-62672-2_28. 

 

2023 

  1. Basim H. Asghar, Radwa K.A. Hassan, Lamiaa A.A. Barakat b, Ahmed Alharbi, M. El Behery, Reda F.M. Elshaarawy , Yasser A. Hassan.2023. "Cross-linked quaternized chitosan nanoparticles for effective delivery and controllable release of O. europaea phenolic extract targeting cancer therapy” Journal of Drug Delivery Science and Technology 83.[Q1 WOS impact factor=5, Cite score=7.6]. 

  1. Al-Warhi, T.; Abu Ali, O.A.; Alqahtani, L.S.; Abo-Elabass, E.; El Behery, M.; El-Baky, A.E.A.; Samir A. Zaki, M.; Fayad, E.; Radwan, E.M. Novel 3-Substituted 8-Methoxycoumarin Derivatives as Anti-Breast Cancer Drugs. Crystals 2023, 13, 1037. [Q2 WOS impact factor=2.7, Cite score=3.6]. 

  1. M. El Behery, Ibrahim M. El-Deen, Manar A. El-Zend, Lamiaa A.A. Barakat, Design, synthesis and evaluation the bioactivities of novel 8‑methoxy-1-azacoumarin-3-carboxamide derivatives as anti-diabetic agents, Journal of Molecular Structure, Volume 1294, Part 2, 2023, 136486. doi.org/10.1016/j.molstruc.2023.136486. [Q2 WOS impact factor=3.8, Citescore=6]. 

  1. Alzamami A, Radwan EM, Abo-Elabass E, El Behery M, Alshwyeh HA, Al-Olayan E, Altamimi AS, Attallah NGM, Altwaijry N, Jaremko M, Saied EM. Novel 8-Methoxycoumarin-3-Carboxamides with potent anticancer activity against liver cancer via targeting caspase-3/7 and β-tubulin polymerization. BMC Chem. 2023 Dec 2;17(1):174. doi: 10.1186/s13065- 023-01063-5. (Q2 WOS IF=4.6, Q2) 

  1. Ali Barakat LA, El-Deen IM, El-Zend MA, El-Behery M. In vitro cytotoxic investigation of some synthesized 1,6-disubstituted-1-azacoumarin derivatives as anticancer agents. Future Med Chem. 2023 Dec;15(24):2289-2307. doi: 10.4155/fmc-2023-0260. (Q3 WOS, Q2 Scopus IF=4.2, Q2, cite score= 6.5) 

  1. Al-Salmi, F.A.; Alrohaimi, A.H.; El Behery, M.; Megahed, W.; Abu Ali, O.A.; Elsaid, F.G.; Fayad, E.; Mohammed, F.Z.; Keshta, A.T. Anticancer Studies of Newly Synthesized Thiazole Derivatives: Synthesis, Characterization, Biological Activity, and Molecular Docking. Crystals 2023, 13, 1546. https://doi.org/10.3390/cryst13111546. [Q3 WOS, Q2 Scopus, impact factor=2.7, Cite score=3.6]. 

 

2022 

  1. F. Z. Mohammed, Y. W. Rizzk, I. M. El-Deen, E. M. Gad, M. El Behery, and A. R. E. Mahdy, “Discovery of 2‐Amino‐4H‐1 3 4‐thiadiazine‐5 (6H) ‐one Derivatives and Their In Vitro Antitumor Investigation,” ChemistrySelect, vol.7, no.7, pp. 1–8, 2022, doi: 10.1002/slct.202104333 www.chemistryselect.org. [Q3 WOS, Q2 Scopus impact factor=2.3]. 

 

  1. Salem, Manar G., Dina M. Abu El-Maaty, Yassmina I. Mohey El-Deen, Basem H. Elesawy, Ahmad El Askary, Asmaa Saleh, Essa M. Saied, and M. El Behery. 2022. "Novel 1,3-Thiazole Analogues with Potent Activity against Breast Cancer: A Design, Synthesis, In Vitro, and In Silico Study" Molecules 27, no. 15: 4898. [Q2 WOS impact factor=4.6, Cite score=6.7]. 

 

2021 

  1. F. Z. Mohammed, W. Rizzk, M. El, A. A. E. Mourad, and M. El Behery, “Design, Synthesis, Cytotoxic Screening and Molecular Docking Studies of Novel Hybrid Thiosemicarbazone Derivatives as Anticancer Agents,” Chem. Biodivers., vol. 18, no.12, pp. 1–18, 2021, doi: 10.1002/cbdv.202100580. [Q3 WOS, Q2 Scopus, impact factor=2.9]. 

  1. A.H. Abu Almaaty, N.A. Elgrahy, E. Fayad, O.A. Abu Ali, A.R.E. Mahdy, L.A.A. Barakat and M. El Behery “Design, Synthesis and Anticancer Evaluation of Substituted Cinnamic Acid Bearing 2-Quinolone Hybrid Derivatives,” molecules, vol. 26, no. 16, pp. 1–14, 2021, doi: 10.3390/molecules26164724. [Q2 WOS impact factor=4.6, Cite score=6.7]. 

  1. A. A. E. Mourad, Y. W. Rizzk, I. Zaki, F. Z. Mohammed, and M. El Behery, “Synthesis and 

cytotoxicity screening of some synthesized hybrid nitrogen molecules as anticancer agents,” 

J. Mol. Struct., vol. 1242, p. 130722, 2021, doi: 10.1016/j.molstruc.2021.130722. [Q3 WOS Q2 Scopus impact factor=3.8, Cite score=6]. 

 

شارك صفحتك الشخصية